Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant

NCT07430059 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity & Overweight

Interventions

COMBINATION_PRODUCT: Semaglutide Implant (NPM-139)
DRUG: Semaglutide (Wegovy) weekly injection

Sponsor

Vivani Medical, Inc

Collaborators

[object Object]